Literature DB >> 12220215

Craniofacial resection of advanced juvenile nasopharyngeal angiofibroma.

Christina Bales1, Mark Kotapka, Laurie A Loevner, Mouwafak Al-Rawi, Gregory Weinstein, Robert Hurst, Randal S Weber.   

Abstract

OBJECTIVE: To describe the results of a craniofacial approach to resection of stage IIIB juvenile nasopharyngeal angiofibroma, performed by an integrated skull base surgical team.
DESIGN: A retrospective case-series review was conducted with postoperative follow-up ranging from 28 to 63 months.
SETTING: Operations were performed at a tertiary medical center. PATIENTS: A referred sample of 5 male patients, ranging in age from 10 to 23 years (mean, 15 years).
INTERVENTIONS: All patients underwent resection of nasopharyngeal angiofibromas with intracranial extension. The procedure involved an infratemporal fossa approach via zygomatic osteotomy and subtemporal craniectomy. Anterior exposure was gained through a standard facial translocation. Dissection of the cavernous carotid artery was required in 3 patients. MAIN OUTCOME MEASURES: Intraoperative and postoperative morbidity.
RESULTS: The average operating time was 12 hours 47 minutes. Estimated blood loss ranged from 700 to 1750 mL (mean, 1120 mL), with 2 patients requiring intraoperative transfusion. Patients were hospitalized for a mean duration of 5.6 days. Long-term morbidity includes facial dysesthesia, nasal crusting, and malodorous nasal discharge. No patients sustained stroke, oculomotor dysfunction, vision loss, or auditory impairment. At most recent follow-up, which ranges from 28 to 63 months, tumor recurrence has been confirmed in 1 patient.
CONCLUSIONS: A combined craniofacial approach is appropriate for juvenile nasopharyngeal angiofibroma that extends intracranially. Complete tumor removal with acceptable morbidity can be expected.

Entities:  

Mesh:

Year:  2002        PMID: 12220215     DOI: 10.1001/archotol.128.9.1071

Source DB:  PubMed          Journal:  Arch Otolaryngol Head Neck Surg        ISSN: 0886-4470


  11 in total

1.  Nasopharyngeal angiofibroma of the nasal cavity.

Authors:  S Marc Stokes; James T Castle
Journal:  Head Neck Pathol       Date:  2010-05-13

2.  Nasopharyngeal Angiofibroma-changing Trends in the Management.

Authors:  Naresh K Panda; Gaurav Gupta; Suresh Sharma; Ashok Gupta
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2011-11-30

3.  Radiological features of juvenile nasopharyngeal angiofibroma.

Authors:  J E Ikubor; N E Okolugbo; A L Okhakhu
Journal:  J West Afr Coll Surg       Date:  2013 Oct-Dec

4.  Combined percutaneous and transarterial devascularisation of juvenile nasopharyngeal angiofibroma with protection of internal carotid artery: A modification of the technique.

Authors:  Ljubisa Borota; Ehab Mahmoud; Christoffer Nyberg; Tomas Ekberg
Journal:  Interv Neuroradiol       Date:  2015-05-19       Impact factor: 1.610

5.  Extensive nasopharyngeal angiofibromas: the maxillary swing approach.

Authors:  Neeraj Narayan Mathur; Ashish Vashishth
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-01-04       Impact factor: 2.503

6.  Endonasal endoscopic management of juvenile nasopharyngeal angiofibroma without angiographic embolization.

Authors:  Asser A El Sharkawy
Journal:  Eur Arch Otorhinolaryngol       Date:  2012-12-28       Impact factor: 2.503

7.  Juvenile nasopharyngeal angiofibroma: current treatment modalities and future considerations.

Authors:  John M Hodges; A S McDevitt; A I El-Sayed Ali; M E Sebelik
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2010-10-12

8.  Management and Outcome in Patients with Advanced Juvenile Nasopharyngeal Angiofibroma.

Authors:  Vedantam Rupa; Sunithi Elizabeth Mani; Selvamani Backianathan; Vedantam Rajshekhar
Journal:  J Neurol Surg B Skull Base       Date:  2017-11-27

9.  Skull base reconstruction in the pediatric patient.

Authors:  Franco Demonte; Brian A Moore; David W Chang
Journal:  Skull Base       Date:  2007-02

10.  Loss of reflex tearing after maxillary orthognathic surgery: a report of two cases.

Authors:  Sunah Kang; Sun Young Jang; Areum Lee; Jae Woo Jang
Journal:  BMC Ophthalmol       Date:  2014-03-28       Impact factor: 2.209

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.